Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

CAI·NASDAQ

$15.48

-1.5%
HealthcareBiotechnology

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

At a Glance

Live Snapshot
Market Cap$4.38B
EPS-1.9000
P/E Ratio-8.15
Earnings Date06/03/2026

cai

Stock Based Compensation

Last Annual Value

70.01M

3-Year CAGR

45%

5-Year CAGR

91%

10-Year CAGR

44%

Caris Life Sciences, Inc.

Caris Life Sciences, Inc. Competitors Analysis of Stock Based Compensation

CAI · NASDAQ
CompanyStock Based Compensation
CAGR 3Y
CAGR 5Y
CAGR 10Y
70.01M
66.2%N/A44.8% 
MRNA logo
Moderna, Inc.
NASDAQ:MRNA
483.00M
16.6%27.7%28.5%
7.68M
-41.4%-14.8%N/A
0.00
N/AN/AN/A
84.50M
20.0%14.5%28.2%
98.13M
25.4%29.6%27.4%
291.13M
8.7%9.0%11.4%
51.56M
12.1%19.9%7.3%
66.82M
27.1%26.3%49.9%
Caris Life Sciences, Inc.

Caris Life Sciences, Inc. Fair Value Envelope

CAI · NASDAQ

Our analysis suggests that CAI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $15.48, this represents a potential HIDDEN relative to our calculated worth for Caris Life Sciences, Inc..

Intrinsic Value
Current Price: $15.48